Skip to main content
Glama

Compare Entities

compare_entities
Read-onlyIdempotent

"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valuesYesFor company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]).

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Added

TDQS

A4.3/5.0
Behavior4/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations indicate safe, idempotent, non-destructive behavior. The description adds context about result sorting by primary metric, citation URIs, and handling of off-calendar fiscal years, providing meaningful behavior beyond annotations.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is a single efficient paragraph, front-loaded with trigger phrases and explicit preference instruction. It is comprehensive without being verbose, though a bulleted structure could improve readability.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness4/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

For a tool comparing two entity types with multiple data sources, the description covers key aspects: data sources, sorting, citation URIs, and replacement of multiple lookups. No output schema exists, but the return type is indicated ('paired data + URIs'). Minor gaps in exact output structure are acceptable given the tool's complexity.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters4/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100%, but the description enhances parameter understanding by explaining what data each entity type retrieves (e.g., 'company' from SEC, 'drug' from FAERS) and clarifying that values should be tickers/CIKs or drug names, adding value beyond schema descriptions.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description clearly states the tool performs side-by-side comparison of 2-5 companies or drugs, specifying detailed data sources for each type (SEC financials, FAERS, FDA approvals, trials). It distinguishes from sibling tools like entity_profile by emphasizing that this tool is for multi-entity comparisons.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description explicitly advises preferring this tool over sequential single-entity lookups, provides example queries, and clarifies entity types. It does not explicitly list cases when not to use, but the context is clear for comparative tasks.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.8/5.0
Disambiguation2/5

Several tools form overlapping families: ask_pipeworx and ask_pipeworx_beta are currently identical, ask_pipeworx_grounded and deep_research cover much of the same router territory, and five Polymarket tools overlap heavily on edge/arbitrage analysis. The descriptions are detailed, but an agent would regularly need to compare multiple near-equivalent candidates before choosing one.

Naming Consistency3/5

Names are consistently snake_case and readable, but the conventions vary widely: verb_noun (search_papers, resolve_entity), noun phrases (entity_profile, polymarket_arbitrage, recent_changes), bare verbs (remember, subscribe, forget), and suffixed variants (ask_pipeworx_beta, ask_pipeworx_grounded). It is not chaotic, but there is no single predictable pattern.

Tool Count2/5

Thirty-five tools is far too many for a server named Paperswithcode, especially since only four tools actually relate to papers while the rest cover data routing, prediction markets, memory, subscriptions, npm auditing, llms.txt generation, and AI visibility. The count feels bloated and the scope unfocused relative to the server's apparent identity.

Completeness3/5

The paper-discovery subdomain is reasonably covered with search, trending, detail, and implementation lookup, and the broader set includes discovery, memory, subscription lifecycle, and feedback tools. However, the overall surface is a patchwork of unrelated domains with no well-defined boundary, and paper datasets/models can only be counted rather than directly listed. Agents can work around most gaps, but the coverage is uneven.